πŸ‡ΊπŸ‡Έ FDA
Patent

US 7803822

Triazole derivative and use thereof

granted A61PA61P1/00A61P1/16

Quick answer

US patent 7803822 (Triazole derivative and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P1/00, A61P1/16, A61P11/00, A61P11/06